Pulmonary embolism secondary to clozapine therapy.
Clozapine is an atypical antipsychotic indicated for paranoid schizophrenia (treatment resistant type). However its use has been limited by the well established association with neutropenia and agranulocytosis. It has also been suggested that clozapine therapy is associated with other serious adverse effects such as fatal myocarditis or cardiomyopathy.